- Home
- VERA vs VEON Comparison
VERA vs VEON Comparison
Compare VERA & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- VEON
- Stock Information
- Founded
- VERA 2016
- VEON 1992
- Country
- VERA United States
- VEON United Arab Emirates
- Employees
- VERA N/A
- VEON N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- VEON Telecommunications Equipment
- Sector
- VERA Health Care
- VEON Telecommunications
- Exchange
- VERA Nasdaq
- VEON Nasdaq
- Market Cap
- VERA 2.0B
- VEON 2.7B
- IPO Year
- VERA 2021
- VEON 1996
- Fundamental
- Price
- VERA $23.20
- VEON $53.55
- Analyst Decision
- VERA Buy
- VEON Strong Buy
- Analyst Count
- VERA 8
- VEON 1
- Target Price
- VERA $64.63
- VEON $60.00
- AVG Volume (30 Days)
- VERA 1.3M
- VEON 282.6K
- Earning Date
- VERA 08-07-2025
- VEON 08-07-2025
- Dividend Yield
- VERA N/A
- VEON N/A
- EPS Growth
- VERA N/A
- VEON N/A
- EPS
- VERA N/A
- VEON 6.56
- Revenue
- VERA N/A
- VEON $4,088,000,000.00
- Revenue This Year
- VERA N/A
- VEON $7.32
- Revenue Next Year
- VERA N/A
- VEON $6.68
- P/E Ratio
- VERA N/A
- VEON $8.21
- Revenue Growth
- VERA N/A
- VEON 8.84
- 52 Week Low
- VERA $18.53
- VEON $25.92
- 52 Week High
- VERA $51.61
- VEON $59.68
- Technical
- Relative Strength Index (RSI)
- VERA 49.75
- VEON 67.42
- Support Level
- VERA $22.57
- VEON $42.54
- Resistance Level
- VERA $24.58
- VEON $59.68
- Average True Range (ATR)
- VERA 1.13
- VEON 2.70
- MACD
- VERA 0.06
- VEON 1.43
- Stochastic Oscillator
- VERA 38.05
- VEON 69.52
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.